Skip to main content
Journal ArticleOPEN ACCESS

Efficacy and safety of sugammadex in patients undergoing renal transplantation

  • Ono Y
  • Fujita Y
  • Kajiura T
  • et al.
JA Clinical Reports (2018) 4(1)
DOI: 10.1186/s40981-018-0192-z
N/ACitations
Citations of this article
13Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Sugammadex reverses rocuronium by encapsulating it, creating a stable complex that is mainly excreted by the kidneys. Nonetheless, in view of exposure to sugammadex during renal transplantation, current safety data are insufficient. We retrospectively investigated the safety and efficacy of sugammadex in the immediate perioperative period and over long-term follow-up.

Cite

CITATION STYLE

APA

Ono, Y., Fujita, Y., Kajiura, T., Okawa, H., Nakashima, J., Isobe, H., & Fujiwara, Y. (2018). Efficacy and safety of sugammadex in patients undergoing renal transplantation. JA Clinical Reports, 4(1). https://doi.org/10.1186/s40981-018-0192-z

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free